SysteMHC v.231201
Home Datasets
Explore
Search atlas
Non-UniProt peptides
Statistics
Atlas stats
Allele stats
PTM stats
Download Help About Update

Showing details for project SYSMHC00057



SampleID NumReplicates Organism TissueType CellType MHCAllele
SampleID NumReplicates Organism TissueType CellType MHCAllele
SYSMHC00057_20210510_A0201_SDBXC_30 2 Human HLA-A02:01
SYSMHC00057_20210510_A0201_SDBXC_FRX 3 Human HLA-A02:01
SYSMHC00057_20210604_A0201_2injections 2 Human HLA-A02:01
SYSMHC00057_20210604_A0201_3injections 3 Human HLA-A02:01
SYSMHC00057_20210604_A0201_FRX 3 Human HLA-A02:01
SYSMHC00057_A0201_FAIMS 2 Human HLA-A02:01
SYSMHC00057_A0201_FAIMS_frx 3 Human HLA-A02:01
SYSMHC00057_A0201_FRX 3 Human HLA-A02:01
SYSMHC00057_A1101_CV 4 Human HLA-A11:01
SYSMHC00057_B0702_CV 4 Human HLA-B07:02
SYSMHC00057_B4901 2 Human HLA-B49:01
SYSMHC00057_B4901_FAIMS 2 Human HLA-B49:01
SYSMHC00057_B5301 2 Human HLA-B53:01
SYSMHC00057_B5301_FAIMS 2 Human HLA-B53:01
SYSMHC00057_HLA_A0201 2 Human HLA-A02:01
SYSMHC00057_MEL_13240-002 2 Human HLA-A02:01,HLA-A24:02,HLA-B15:01,HLA-B44:02,HLA-C05:01,HLA-C07:02
SYSMHC00057_MEL_13240-002_FAIMS 2 Human HLA-A02:01,HLA-A24:02,HLA-B15:01,HLA-B44:02,HLA-C05:01,HLA-C07:02
SYSMHC00057_MEL_13240-002_frx 6 Human HLA-A02:01,HLA-A24:02,HLA-B15:01,HLA-B44:02,HLA-C05:01,HLA-C07:02
SYSMHC00057_MEL_13240-011_Exploris 2 Human HLA-A66:01,HLA-A01:03,HLA-B08:01,HLA-C07:01
SYSMHC00057_MEL_13240-011_FAIMS_Exploris 2 Human HLA-A66:01,HLA-A01:03,HLA-B08:01,HLA-C07:01
SYSMHC00057_MEL_13240-011_FRX_Exploris 3 Human HLA-A66:01,HLA-A01:03,HLA-B08:01,HLA-C07:01
SYSMHC00057_MEL_13240-011_FRX_FAIMS_Exploris 3 Human HLA-A66:01,HLA-A01:03,HLA-B08:01,HLA-C07:01
SYSMHC00057_MEL_13240-011_FRX_FAIMS_Lumos 3 Human HLA-A66:01,HLA-A01:03,HLA-B08:01,HLA-C07:01
SYSMHC00057_MEL_13240-011_FRX_Lumos 3 Human HLA-A66:01,HLA-A01:03,HLA-B08:01,HLA-C07:01
SYSMHC00057_RCC_16097-104_tumorprimary_frx 3 Human HLA-A01:01,HLA-A30:01,HLA-B08:01,HLA-B13:02,HLA-C06:02,HLA-C07:01
SYSMHC00057_RCC_16097-105_tumor_FAIMS 2 Human HLA-A01:01,HLA-B08:01,HLA-C07:01
SYSMHC00057_RCC_16097-105_tumor_FAIMS_frx 3 Human HLA-A01:01,HLA-B08:01,HLA-C07:01
SYSMHC00057_RCC_16097-105_tumor_frx 3 Human HLA-A01:01,HLA-B08:01,HLA-C07:01
SYSMHC00057_RCC_16097_101_tumor 2 Human HLA-A01:01,HLA-A66:01,HLA-B57:01,HLA-B40:01,HLA-C06:02,HLA-C03:04
SYSMHC00057_RCC_16097_101_tumor_FAIMS 2 Human HLA-A01:01,HLA-A66:01,HLA-B57:01,HLA-B40:01,HLA-C06:02,HLA-C03:04
SYSMHC00057_RCC_16097_101_tumor_frx 7 Human HLA-A01:01,HLA-A66:01,HLA-B57:01,HLA-B40:01,HLA-C06:02,HLA-C03:04
SYSMHC00057_RCC_16097_102_tumor 2 Human HLA-A02:01,HLA-B38:01,HLA-B35:03,HLA-C12:03
SYSMHC00057_RCC_16097_102_tumor_FAIMS 2 Human HLA-A02:01,HLA-B38:01,HLA-B35:03,HLA-C12:03
SYSMHC00057_RCC_16097_102_tumor_FRX 4 Human HLA-A02:01,HLA-B38:01,HLA-B35:03,HLA-C12:03
SYSMHC00057_RCC_16097_102_tumor_FRXFAIMS 4 Human HLA-A02:01,HLA-B38:01,HLA-B35:03,HLA-C12:03
SYSMHC00057_RCC_16097_104_Metastasis_FAIMS 2 Human HLA-A01:01,HLA-A30:01,HLA-B08:01,HLA-B13:02,HLA-C06:02,HLA-C07:01
SYSMHC00057_RCC_16097_104_Metastasis_FAIMS_frx 6 Human HLA-A01:01,HLA-A30:01,HLA-B08:01,HLA-B13:02,HLA-C06:02,HLA-C07:01
SYSMHC00057_RCC_16097_104_Metastasis_frx 3 Human HLA-A01:01,HLA-A30:01,HLA-B08:01,HLA-B13:02,HLA-C06:02,HLA-C07:01
SYSMHC00057_RCC_16097_104_metastasis 2 Human HLA-A01:01,HLA-A30:01,HLA-B08:01,HLA-B13:02,HLA-C06:02,HLA-C07:01
SYSMHC00057_RCC_16097_104_tumorprimary 2 Human HLA-A01:01,HLA-A30:01,HLA-B08:01,HLA-B13:02,HLA-C06:02,HLA-C07:01
SYSMHC00057_RCC_16097_104_tumorprimary_FAIMS 2 Human HLA-A01:01,HLA-A30:01,HLA-B08:01,HLA-B13:02,HLA-C06:02,HLA-C07:01
SYSMHC00057_RCC_16097_104_tumorprimary_FAIMS_frx 3 Human HLA-A01:01,HLA-A30:01,HLA-B08:01,HLA-B13:02,HLA-C06:02,HLA-C07:01



Detailed view of sample SYSMHC00057_RCC_16097-104_tumorprimary_frx



ID SampleID RawFileName Organism Process Tissue Type Cell Type Culture Conditions Disease State Comments MHCClass MHCAllele PubMed ID Peptide Isolation Method Antibody Mass Spectrometer LC System iRT Peptides Acquisition Mode Fragmentation Method Gradient Gradient Length Flow Rate Replicate Number
ID SampleID RawFileName Organism Process Tissue_Type Cell_Type Culture_Conditions Disease_State Comments MHCClass MHCAllele PubMed_ID Peptide Isolation_Method Antibody Mass_Spectrometer LC_System iRT_Peptides Acquisition_Mode Fragmentation_Method Gradient Gradient_Length Flow_Rate Replicate_Number
SYSMHC00057 SYSMHC00057_RCC_16097-104_tumorprimary_frx AQ20191025_SK_HLA_16097_104_tumorprimary_RCC_2IPsa0p1g_fxn3.raw Human In vitro Renal Renal cell adherent Renal cell carcinoma class I HLA-A01:01,HLA-A30:01,HLA-B08:01,HLA-B13:02,HLA-C06:02,HLA-C07:01 34391888 native Immunoaffinity W6/32 Q-Exactive EasyNanoLC 1200 no DDA HCD 1
SYSMHC00057 SYSMHC00057_RCC_16097-104_tumorprimary_frx AQ20191025_SK_HLA_16097_104_tumorprimary_RCC_2IPsa0p1g_fxn1.raw Human In vitro Renal Renal cell adherent Renal cell carcinoma class I HLA-A01:01,HLA-A30:01,HLA-B08:01,HLA-B13:02,HLA-C06:02,HLA-C07:01 34391888 native Immunoaffinity W6/32 Q-Exactive EasyNanoLC 1200 no DDA HCD 2
SYSMHC00057 SYSMHC00057_RCC_16097-104_tumorprimary_frx AQ20191025_SK_HLA_16097_104_tumorprimary_RCC_2IPsa0p1g_fxn2.raw Human In vitro Renal Renal cell adherent Renal cell carcinoma class I HLA-A01:01,HLA-A30:01,HLA-B08:01,HLA-B13:02,HLA-C06:02,HLA-C07:01 34391888 native Immunoaffinity W6/32 Q-Exactive EasyNanoLC 1200 no DDA HCD 3